Carlos Moran

Dec 5, 2024 | genomebiology.biomedcentral.com | Carlos Moran |Carlos Morán |Paola Ramos |Outcomes Research |Yamila Caraballo

Each patient-tumor sample had a 1-mm sample obtained from a region of tumor and stroma near the respective tumor-stroma interface. SMI was obtained on 3 tissue microarrays (TMAs) using the Human Immuno-Oncology Panel (consisting of 978 RNA probes). Between stromal and tumor primary-disease fields of view (FOV), 40 FOV passed the applied quality filters (see Methods, Table 1, Additional File 1: Fig. S1, Additional File 2: Table S1.